ArticleFrontiers in oncology2022

Anlotinib combined with TAS-102 as the third-line treatment for a patient with metastatic colon cancer: A case report.

Qizheng Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.